ABL1 and acute lymphoblastic leukemia: Significant associations between ACR changes and Dasatinib/Imatinib were observed particularly in BCR::ABL1\BCR::ABL1-like B-ALL samples, in line with the fact that these drugs are widely used for treating BCR::ABL1\BCR::ABL1-like B-ALL patients in clinic45.